SABBY MANAGEMENT, LLC

MIAMI BEACH, FL · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$6.7M2026 Q3+ $2.3M options (notional, not included)
Positions21
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.78.6%

SABBY MANAGEMENT, LLC reported 21 positions worth $6.7M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: TOYO (23.3%). Biggest move: exit SPY ($4.1M).

10 / 21 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 TOYOTOYO$2.1M23.26%482,175———
▸ 2Sidus SpacePutSidus Space$967.8K notional10.73%3,787———
▸ 3 PNPN Smart Energy$737.1K8.17%269,000———
▸ 4 YXTYxt.Com$646.6K7.17%286,085———
▸ 5 ZVRAZevra Therapeutics$634.6K7.04%57,850——-17.2%
▸ 6 CRVOCervoMed$593.0K6.58%199,678———
▸ 7 APVOAptevo Therapeutics$423.5K4.70%232,692——-31.9%
▸ 8Zevra Therape…PutZevra Therapeutics$375.8K notional4.17%864———
▸ 9State Str Spd…PutState STR SPDR$332.8K notional3.69%405———
▸ 10IsharesPutIshares$280.6K notional3.11%441———

Pro Feature

The remaining 11 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does SABBY MANAGEMENT, LLC hold as of Q3 2026?

SABBY MANAGEMENT, LLC reported 21 positions worth $6.7M in its Q3 2026 13F filing. Largest positions: TOYO (23.3%), SIDUS SPACE INC (10.7%), PN (8.2%), YXT (7.2%) and ZVRA (7.0%).

What did SABBY MANAGEMENT, LLC buy in Q3 2026?

New positions: PN, YXT, ZVRA, APVO and IWM (8 in all). Added to: SIDUS SPACE INC, ZEVRA THERAPEUTICS INC, SENESTECH INC, STATE STR SPDR S&P 500 ETF and SIDU.

What did SABBY MANAGEMENT, LLC sell in Q3 2026?

Reduced: STATE STR SPDR S&P 500 ETF, CRVO, TOYO, REVELATION BIOSCIENCES INC and BCTXL (6 in all). Sold out entirely: SPY, ABIVAX SA, FARMMI INC, TEMPEST THERAPEUTICS INC and BIOAFFINITY TECHNOLOGIES (10 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.